by TractManager | May 25, 2017 | Health Technology Assessment
Purpose of Technology: Roux-en-Y gastric bypass (RYGB) is surgery that reduces the capacity of the stomach and the length of the small intestine through which food travels. RYGB is widely accepted as very effective for weight loss in people with morbid obesity;...
by TractManager | May 18, 2017 | Health Technology Assessment
Approximately 26,070 primary malignant and 53,200 nonmalignant brain tumors will be diagnosed in the United States in 2017, with an estimated 16,947 deaths in the United States in 2017 attributable to primary malignant brain and central nervous system...
by TractManager | May 18, 2017 | Clinical Utility Evaluation
This report examines the clinical utility of pharmacogenomic testing to inform the selection or dose of medications for individuals diagnosed with depression, mood disorders, psychosis, anxiety, attention-deficit/hyperactivity disorder, or substance use disorder....
by TractManager | May 11, 2017 | Health Technology Assessment
Purpose of Technology: Lymphedema is the swelling of limbs caused by fluid accumulation, most commonly due to lymphatic injury caused by cancer treatment. Conservative management may confer insufficient control or be ineffective altogether, especially if lymphedema is...
by TractManager | May 10, 2017 | Emerging Technology Report
Radicava is a newly FDA-approved intravenously administered free radical scavenger for the treatment of amyotrophic lateral sclerosis (ALS). Oxidative stress has been considered to be involved in the onset and progression of ALS; it’s postulated that elimination of...
Recent Comments